Psychedelic Medicine: A New Paradigm in Mental Health
Psychedelic-assisted psychotherapy is poised to be an important breakthrough in the treatment of mental illness in this generation. Phase III trials for MDMA-assisted psychotherapy are close to completion and government regulation of MDMA and psilocybin are expected within the next 1-3 years.
This interactive, one-day educational event will offer an overview of psychedelic-assisted psychotherapy from a clinical perspective. This event is virtual, held via Zoom.
No prior knowledge or background with psychedelics or psychedelic-assisted therapy is necessary to attend and benefit from this educational event, which is intended to provide an introduction to the field. Members of the community and clinicians from a variety of health disciplines are encouraged to attend!